对比剂驱动的人为钆:已知与未知
本文综述钆基对比剂(GBCA)经未使用产品处置和静脉注射后排泄进入环境形成人为钆的现有知识,阐述螯合物解离的化学原理,并给出问题规模最不可能造成人类伤害的推断性观点,讨论尿液收集、低剂量高弛豫率大环GBCA及虚拟对比增强检查等缓解策略的优劣,提出骨骼钆监测方向与未来研究建议。
要点
- 人为钆源于GBCA未使用产品处置和注射后排泄进入水系统,引发潜在不良影响担忧并促使部分缓解行动。
- 作者推断该问题规模最不可能造成人类伤害,并讨论螯合物解离的化学原理。
- 缓解策略包括收集给药后尿液、使用低剂量高弛豫率大环GBCA及虚拟对比增强检查选项。
核心结论
- 作者提供推断性观点:人为钆问题的规模最不可能造成人类伤害。
研究设计与样本
- 本文为综述,总结现有知识、问题范围、螯合物解离的化学原理、缓解策略的优劣、骨骼钆监测潜力及未来研究建议。
临床应用与阅片要点
- 原文讨论了收集GBCA给药后尿液、使用低剂量高弛豫率大环GBCA及虚拟对比增强检查等可能缓解策略的优劣。
- 原文提出可监测骨骼中的钆摄取。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Gadolinium-based contrast agents (GBCAs) have augmented the capabilities of MRI, which has led to their widespread and increasing use in radiology practice. GBCAs are introduced into the environment through disposal of unused product and elimination after intravenous injection, both primarily via liquid dispersion into the environment. This human introduction of gadolinium into the environment, referred to as anthropogenic gadolinium, is associated with the detection of gadolinium in water systems, raising concerns for potential adverse impact and prompting certain mitigation actions. This article summarizes the existing knowledge and problem scope, conveys the relevant underlying chemical principles of chelate dissociation, and offers an inferred perspective that the magnitude of the problem is most unlikely to cause human harm. The merits and limitations regarding possible mitigation tactics, such as collecting urine after GBCA administration, use of lower-dose high-relaxivity macrocyclic GBCAs, and the option for virtual contrast-enhanced examinations, will be discussed. Finally, the potential for monitoring gadolinium uptake in bone will be presented, and recommendations for future research will be offered. © RSNA, 2024 See also the article by Ibrahim et al in this issue. See also the article by McKee et al in this issue.
引用
- Lenkinski RE, Rofsky NM. Contrast Media-driven Anthropogenic Gadolinium: Knowns and Unknowns. Radiology. 2024. PMID: 38652027. doi:10.1148/radiol.240020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。